12014-65-2

CeIr5

Salor-Int L428507-1ea

diphenylmethyl N-[(benzyloxy)carbonyl]glycinate

1H-Benzimidazole-1-acetic acid,2-[[[1-(4-bromobenzoyl)-3-piperidinyl]methyl]thio]-5-fluoro-

1-[2-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-2-oxoethyl]piperidinium (2Z)-3-carboxyprop-2-enoate

dichlorozinc; tributoxyphosphonium

2-Pyridinecarboxaldehyde, 6-methyl-5-nitro-,[4-(4-chlorophenyl)-2-thiazolyl]hydrazone

Piperazine,1-[5-(3-furanyl)-2-pyridinyl]-4-[[2-(hydroxyamino)-5-(2-pyrimidinyl)pentyl]sulfonyl]-

1H-Benzimidazole-1-acetic acid,5-fluoro-2-[[[1-(1-oxobutyl)-3-piperidinyl]methyl]thio]-, 1,1-dimethylethylester

2-Quinolinecarboxylic acid,4-[3-[[(1,1-dimethylethoxy)carbonyl]amino]propyl]-8-hydroxy-, methylester

Benzo[b]thiophene-3-acetic acid,5-[[(2R,3S)-2,3-dimethyl-4-[5-(trifluoromethyl)-2-pyridinyl]-1-piperazinyl]sulfonyl]-, rel-

1-(4-Nitrophenyl)cyclopropanecarboxamide

with 1, 3-diisocyanatomethyl-benzene and

4-Hexen-2-yn-1-ol, 6-[[(1,1-dimethylethyl)diphenylsilyl]oxy]-

1H-Indene-2-carboxylic acid,4-[[(2R,6S)-2,6-dimethyl-4-[4-[(trifluoromethyl)thio]phenyl]-1-piperazinyl]sulfonyl]-2,3-dihydro-, rel-

2-(4-{(Z)-[1-(2-hydroxyethyl)-3,5-dimethyl-1H-pyrazol-4-yl]-NNO-azoxy}-3,5-dimethyl-1H-pyrazol-1-yl)ethanol

N-Boc-(S)-2-(methylamino)propan-1-ol

1H-Indene-1-carboxylic acid,6-[[3,3-dimethyl-4-[5-(trifluoromethyl)-2-pyridinyl]-1-piperazinyl]sulfonyl]-2,3-dihydro-

4-methyl-1,8-naphthyridine-2,7(1H,8H)-dione

1,11-Pentacenediamine, 4,8-dinitro-

N,N-dimethyl-2-(2-phenyl-6,7-dihydroindolo[1,7-ab][1]benzazepin-1-yl)ethanamine

Cyclopropaneacetic acid, 1-[(4-hydroxyphenyl)methyl]-

2-Chloro-4-fluoro-5-iodobenzoic acid

2-Pyridinamine, 5-chloro-N-(1H-1,2,4-triazol-1-ylmethyl)-

2-Pyridinamine, 6-[(aminooxy)methyl]-3-(2-thienyl)-

8H-Pyrrolo[3,4-g]quinolin-8-one,7-[(4-fluorophenyl)methyl]-6,7-dihydro-9-hydroxy-5-(2-phenylethenyl)-

ethyl N-(thiophen-2-ylcarbonyl)-L-cysteinate

Benzaldehyde, 2,6-diethyl-

2-Propyn-1-one, 3-(2-aminophenyl)-1-(3-fluorophenyl)-

Pyrazine, ((2-furanylmethyl)thio)methyl- (9CI)

Benzenamine,4-methoxy-N-[1-methyl-2-(methylphenylamino)ethylidene]-

Morpholine, 4-(1-methylenenonyl)-

gamma-glutamyl-S-(4-bromo-6-hydroxycyclohexa-2,4-dien-1-yl)cysteinylglycine

2-[3-(4-chlorophenyl)-1-phenyl-1H-pyrazol-4-yl]-3-(furan-2-ylmethyl)-1,3-thiazolidin-4-one

(2R,2'R)-3,3'-[(2-hydroxypropane-1,3-diyl)disulfanediyl]bis[2-(acetylamino)propanoic acid]

4-{[9-({2-methoxy-4-[(methylsulfonyl)amino]phenyl}amino)acridin-4-yl]oxy}butanamide

[hydroxyacetato(2-)-O1,O2]bis[4-(1-methyl-1-phenylethyl)phenolato]titanium

12014-65-2 msds

CAS No 12014-65-2 supplier

CASNo 12014-65-2 distributor

CAS # 12014-65-2 manufacturer

CAS Number 12014-65-2 safety

CAS RN 12014-65-2 wholesale

2025-12-21 ,CAS No.12014-65-2,Formula:CeIr5. Find Related Products for Bulk Production or Scientific Research